Danny Gibson
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
An Unanchored Matching-Adjusted Indirect Comparison of Dupilumab and Tezepelumab in Asthma Has Several Limitations.
Journal: The journal of allergy and clinical immunology. In practice
Published: June 12, 2026
Indirect Treatment Comparison of Tezepelumab Versus Other Biologics in Severe Chronic Rhinosinusitis with Nasal Polyps: A Systematic Literature Review and Network Meta-analysis.
Journal: Advances in therapy
Published: March 13, 2026
Modelling Adverse Events in Patients Receiving Chronic Oral Corticosteroids in the UK.
Journal: PharmacoEconomics - open
Published: August 11, 2024
Cost-effectiveness of tezepelumab in Canada for severe asthma.
Journal: Journal of medical economics
Published: July 07, 2023
Longitudinal patterns of intermittent oral corticosteroid therapy for asthma in the United Kingdom.
Journal: The journal of allergy and clinical immunology. Global
Published: June 07, 2023
Adverse Outcomes, Healthcare Resource Utilization, and Costs Associated with Systemic Corticosteroid use Among Adults with Systemic Lupus Erythematosus in the UK.
Journal: Rheumatology and therapy
Published: January 26, 2023
Healthcare Resource Use and Costs Associated with Organ Damage in Newly Diagnosed Adults with Systemic Lupus Erythematosus in the UK.
Journal: Rheumatology and therapy
Published: January 26, 2023
Healthcare costs associated with short-acting β2-agonists in asthma: observational UK SABINA study.
Journal: BJGP open
Published: January 24, 2023
The cost-effectiveness of as-needed budesonide/formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in the UK.
Journal: Respiratory medicine
Published: May 29, 2020
Showing 1-10 of 10
Last Updated: 09/26/2026